Vir Biotechnology IncVIR
Price$11.18Intrinsic value$9.4216% below price

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $68.6M-7.6% YoYTTM through 30 Jun 2026
Net Income -$251.7MTTM through 30 Jun 2026
Free Cash Flow -$203.6MTTM through 30 Jun 2026

Margins

Current
EBITDA Margin-391.9%
Operating Margin456,172.0%
Net Margin-367.1%

Returns

-15.5%ROE
-12.3%ROA

Balance Sheet Health

Debt / Equity0.00x
Current Ratio7.11x
Net Debt-$470.4Mnet cash position
Cash & Equivalents$278.7M

Quality Metrics

Altman Z-Score3.36
Piotroski F-Score2 / 9
FCF Margin-297.0%
Earnings-Beat Rate25.0%

Multi-Year Trend

Revenue
'19'20'21'22'23'24'25
FY2025: $68.6M
Diluted EPS-$1.77TTM
'19'20'21'22'23'24'25
FY2025: $-3.16

Dividend

No dividend

Capital Allocation

Capex Intensity1.6%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.